<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35505308</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1471-2334</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>03</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMC infectious diseases</Title>
          <ISOAbbreviation>BMC Infect Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Accuracy of a score predicting the presence of an atypical pathogen in hospitalized patients with moderately severe community-acquired pneumonia.</ArticleTitle>
        <Pagination>
          <StartPage>424</StartPage>
          <MedlinePgn>424</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">424</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-022-07423-1</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Atypical pathogens (AP), present in some patients with community-acquired pneumonia (CAP), are intrinsically resistant to betalactam drugs, the mainstay of empirical antibiotic treatment. Adding antibiotic coverage for AP increases the risk of adverse effects and antimicrobial selection pressure, while withholding such coverage may worsen the prognosis if an AP is causative. A clinical model predicting the presence of AP would allow targeting atypical coverage for patients most likely to benefit.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">This is a secondary analysis of a multicentric randomized controlled trial that included 580 adults patients hospitalized for CAP. A predictive score was built using independent predictive factors for AP identified through multivariate analysis. Accuracy of the score was assessed using area under the receiver operating curve (AUROC), sensitivity, and specificity.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Prevalence of AP was 5.3%. Age &lt; 75 years (OR 2.7, 95% CI 1.2-6.2), heart failure (OR 2.6, 95% CI 1.1-6.1), absence of chest pain (OR 3.0, 95% CI 1.1-8.2), natremia &lt; 135 mmol/L (OR 3.0, 95% CI 1.4-6.6) and contracting the disease in autumn (OR 2.7, 95% CI 1.3-5.9) were independently associated with AP. A predictive score using these factors had an AUROC of 0.78 (95% CI 0.71-0.85). A score of 0 or 1 (present in 33% of patients) had 100% sensitivity and 35% specificity.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Use of a score built on easily obtained clinical and laboratory data would allow safe withholding of atypical antibiotic coverage in a significant number of patients, with an expected positive impact on bacterial resistance and drug adverse effects.</AbstractText>
          <AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">NCT00818610.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chauffard</LastName>
            <ForeName>Aline</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bridevaux</LastName>
            <ForeName>Pierre-Olivier</ForeName>
            <Initials>PO</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Service de Pneumologie, Centre Hospitalier du Valais Romand, Hôpital du Valais, Sion, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carballo</LastName>
            <ForeName>Sebastian</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of General Internal Medicine, Hôpitaux Universitaires de Genève, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Prendki</LastName>
            <ForeName>Virginie</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reny</LastName>
            <ForeName>Jean-Luc</ForeName>
            <Initials>JL</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of General Internal Medicine, Hôpitaux Universitaires de Genève, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stirnemann</LastName>
            <ForeName>Jérôme</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of General Internal Medicine, Hôpitaux Universitaires de Genève, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Garin</LastName>
            <ForeName>Nicolas</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland. Nicolas.Garin@hopitalrivierachablais.ch.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of General Internal Medicine, Hôpitaux Universitaires de Genève, Geneva, Switzerland. Nicolas.Garin@hopitalrivierachablais.ch.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Internal Medicine, Hôpital Riviera Chablais, Rennaz, Switzerland. Nicolas.Garin@hopitalrivierachablais.ch.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Service de Médecine Interne, Centre Hospitalier de Rennaz, Rte du Vieux Séquoia 20, 1847, Rennaz, Switzerland. Nicolas.Garin@hopitalrivierachablais.ch.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <DataBankList CompleteYN="Y">
          <DataBank>
            <DataBankName>ClinicalTrials.gov</DataBankName>
            <AccessionNumberList>
              <AccessionNumber>NCT00818610</AccessionNumber>
            </AccessionNumberList>
          </DataBank>
        </DataBankList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>BMC Infect Dis</MedlineTA>
        <NlmUniqueID>100968551</NlmUniqueID>
        <ISSNLinking>1471-2334</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D047090">beta-Lactams</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019072" MajorTopicYN="N">Antibiotic Prophylaxis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017714" MajorTopicYN="Y">Community-Acquired Infections</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011014" MajorTopicYN="Y">Pneumonia</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D047090" MajorTopicYN="N">beta-Lactams</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Atypical pathogen</Keyword>
        <Keyword MajorTopicYN="N">Community-acquired pneumonia</Keyword>
        <Keyword MajorTopicYN="N">Legionella pneumophila</Keyword>
        <Keyword MajorTopicYN="N">Mycoplasma pneumoniae</Keyword>
        <Keyword MajorTopicYN="N">Predictive factor</Keyword>
        <Keyword MajorTopicYN="N">Predictive score</Keyword>
      </KeywordList>
      <CoiStatement>The authors have no conflicts of interest to declare.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>23</Hour>
          <Minute>45</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35505308</ArticleId>
        <ArticleId IdType="pmc">PMC9066797</ArticleId>
        <ArticleId IdType="doi">10.1186/s12879-022-07423-1</ArticleId>
        <ArticleId IdType="pii">10.1186/s12879-022-07423-1</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Shoar S, Musher DM. Etiology of community-acquired pneumonia in adults: a systematic review. Pneumonia (Nathan) 2020;12:11. doi: 10.1186/s41479-020-00074-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s41479-020-00074-3</ArticleId>
            <ArticleId IdType="pmc">PMC7533148</ArticleId>
            <ArticleId IdType="pubmed">33024653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Torres A, et al.  Pneumonia. Nat Rev Dis Primers. 2021;7(1):25. doi: 10.1038/s41572-021-00259-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41572-021-00259-0</ArticleId>
            <ArticleId IdType="pubmed">33833230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Torres A, et al.  The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis. 2014;33(7):1065–1079. doi: 10.1007/s10096-014-2067-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-014-2067-1</ArticleId>
            <ArticleId IdType="pmc">PMC4042014</ArticleId>
            <ArticleId IdType="pubmed">24532008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cilloniz C, et al.  Community-acquired pneumonia related to intracellular pathogens. Intensive Care Med. 2016;42(9):1374–1386. doi: 10.1007/s00134-016-4394-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00134-016-4394-4</ArticleId>
            <ArticleId IdType="pubmed">27276986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farr BM, et al.  Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee. Thorax. 1989;44(12):1031–1035. doi: 10.1136/thx.44.12.1031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/thx.44.12.1031</ArticleId>
            <ArticleId IdType="pmc">PMC1020880</ArticleId>
            <ArticleId IdType="pubmed">2515602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arnold FW, et al.  A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007;175(10):1086–1093. doi: 10.1164/rccm.200603-350OC.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.200603-350OC</ArticleId>
            <ArticleId IdType="pubmed">17332485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wellinghausen N, et al.  Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia. Int J Med Microbiol. 2006;296(7):485–491. doi: 10.1016/j.ijmm.2006.05.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijmm.2006.05.003</ArticleId>
            <ArticleId IdType="pubmed">16890487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Senn L, et al.  Does respiratory infection due to Chlamydia pneumoniae still exist? Clin Infect Dis. 2011;53(8):847–848. doi: 10.1093/cid/cir515.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cir515</ArticleId>
            <ArticleId IdType="pubmed">21921229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>von Baum H, et al.  Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ) BMC Infect Dis. 2009;9:62. doi: 10.1186/1471-2334-9-62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2334-9-62</ArticleId>
            <ArticleId IdType="pmc">PMC2689234</ArticleId>
            <ArticleId IdType="pubmed">19439072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allgaier J, et al.  Risk factors, management, and outcomes of Legionella pneumonia in a large, nationally representative sample. Chest. 2021;159(5):1782–1792. doi: 10.1016/j.chest.2020.12.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chest.2020.12.013</ArticleId>
            <ArticleId IdType="pubmed">33352192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain S, et al.  Community-acquired pneumonia requiring hospitalization among US adults. N Engl J Med. 2015;373(5):415–427. doi: 10.1056/NEJMoa1500245.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1500245</ArticleId>
            <ArticleId IdType="pmc">PMC4728150</ArticleId>
            <ArticleId IdType="pubmed">26172429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Metlay JP, et al.  Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45–e67. doi: 10.1164/rccm.201908-1581ST.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.201908-1581ST</ArticleId>
            <ArticleId IdType="pmc">PMC6812437</ArticleId>
            <ArticleId IdType="pubmed">31573350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ewig S, Giesa C. Update: guidelines for the treatment and prevention of adult community-acquired pneumonia 2016: what is new? MMW Fortschr Med. 2017;159(3):51–52. doi: 10.1007/s15006-017-9278-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s15006-017-9278-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woodhead M, et al.  Guidelines for the management of adult lower respiratory tract infections–full version. Clin Microbiol Infect. 2011;17(Suppl 6):E1–59. doi: 10.1111/j.1469-0691.2011.03672.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-0691.2011.03672.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garin N, et al.  beta-Lactam monotherapy vs beta-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. JAMA Intern Med. 2014;174(12):1894–1901. doi: 10.1001/jamainternmed.2014.4887.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamainternmed.2014.4887</ArticleId>
            <ArticleId IdType="pubmed">25286173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165(6):710–718. doi: 10.1093/aje/kwk052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/aje/kwk052</ArticleId>
            <ArticleId IdType="pubmed">17182981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glas AS, et al.  The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56(11):1129–1135. doi: 10.1016/S0895-4356(03)00177-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0895-4356(03)00177-X</ArticleId>
            <ArticleId IdType="pubmed">14615004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lui G, et al.  Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia. Respirology. 2009;14(8):1098–1105. doi: 10.1111/j.1440-1843.2009.01637.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1440-1843.2009.01637.x</ArticleId>
            <ArticleId IdType="pubmed">19818051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Plouffe JF. Importance of atypical pathogens of community-acquired pneumonia. Clin Infect Dis. 2000;31(Suppl 2):S35–S39. doi: 10.1086/314058.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/314058</ArticleId>
            <ArticleId IdType="pubmed">10984326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fiumefreddo R, et al.  Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department. BMC Pulm Med. 2009;9:4. doi: 10.1186/1471-2466-9-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2466-9-4</ArticleId>
            <ArticleId IdType="pmc">PMC2636761</ArticleId>
            <ArticleId IdType="pubmed">19152698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saraya T, et al.  A novel diagnostic scoring system to differentiate between Legionella pneumophila Pneumonia and Streptococcus pneumoniae Pneumonia. Intern Med. 2018;57(17):2479–2487. doi: 10.2169/internalmedicine.0491-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2169/internalmedicine.0491-17</ArticleId>
            <ArticleId IdType="pmc">PMC6172550</ArticleId>
            <ArticleId IdType="pubmed">29607950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandez-Sabe N, et al.  Clinical diagnosis of Legionella pneumonia revisited: evaluation of the Community-Based Pneumonia Incidence Study Group scoring system. Clin Infect Dis. 2003;37(4):483–489. doi: 10.1086/376627.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/376627</ArticleId>
            <ArticleId IdType="pubmed">12905131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sopena N, et al.  Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. Chest. 1998;113(5):1195–1200. doi: 10.1378/chest.113.5.1195.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.113.5.1195</ArticleId>
            <ArticleId IdType="pubmed">9596294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Viasus D, et al.  Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years. Medicine (Baltimore) 2013;92(1):51–60. doi: 10.1097/MD.0b013e31827f6104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0b013e31827f6104</ArticleId>
            <ArticleId IdType="pmc">PMC5348137</ArticleId>
            <ArticleId IdType="pubmed">23266795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haubitz S, et al.  Ruling out Legionella in community-acquired pneumonia. Am J Med. 2014;127(10):1010.e11–9. doi: 10.1016/j.amjmed.2014.03.042.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjmed.2014.03.042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arancibia F, et al.  Importance of Legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago Chile. Chest. 2014;145(2):290–296. doi: 10.1378/chest.13-0162.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.13-0162</ArticleId>
            <ArticleId IdType="pubmed">23764871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Falco V, et al.  Legionella pneumophila. A cause of severe community-acquired pneumonia. Chest. 1991;100(4):1007–1011. doi: 10.1378/chest.100.4.1007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.100.4.1007</ArticleId>
            <ArticleId IdType="pubmed">1914547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta SK, Imperiale TF, Sarosi GA. Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia. Chest. 2001;120(4):1064–1071. doi: 10.1378/chest.120.4.1064.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.120.4.1064</ArticleId>
            <ArticleId IdType="pubmed">11591540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farnham A, et al.  Legionnaires' disease incidence and risk factors, New York, New York, USA, 2002–2011. Emerg Infect Dis. 2014;20(11):1795–1802. doi: 10.3201/eid2011.131872.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2011.131872</ArticleId>
            <ArticleId IdType="pmc">PMC4214295</ArticleId>
            <ArticleId IdType="pubmed">25513657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garcia-Vidal C, et al.  Rainfall is a risk factor for sporadic cases of Legionella pneumophila pneumonia. PLoS ONE. 2013;8(4):e61036. doi: 10.1371/journal.pone.0061036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0061036</ArticleId>
            <ArticleId IdType="pmc">PMC3628787</ArticleId>
            <ArticleId IdType="pubmed">23613778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cilloniz C, et al.  Seasonality of pathogens causing community-acquired pneumonia. Respirology. 2017;22(4):778–785. doi: 10.1111/resp.12978.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/resp.12978</ArticleId>
            <ArticleId IdType="pubmed">28093834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kenagy E, et al.  Risk factors for Legionella longbeachae Legionnaires' disease New Zealand. Emerg Infect Dis. 2017;23(7):1148–1154. doi: 10.3201/eid2307.161429.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2307.161429</ArticleId>
            <ArticleId IdType="pmc">PMC5512494</ArticleId>
            <ArticleId IdType="pubmed">28628460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>von Baum H, Luck C. Community-acquired Legionella pneumonia: data from the CAPNETZ study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011;54(6):688–692. doi: 10.1007/s00103-011-1287-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00103-011-1287-0</ArticleId>
            <ArticleId IdType="pubmed">21626372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roed T, Schonheyder HC, Nielsen H. Predictors of positive or negative Legionella urinary antigen test in community-acquired pneumonia. Infect Dis (Lond) 2015;47(7):484–490. doi: 10.3109/23744235.2015.1021830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/23744235.2015.1021830</ArticleId>
            <ArticleId IdType="pubmed">25761613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyashita N, et al.  Clinical presentation of legionella pneumonia: evaluation of clinical scoring systems and therapeutic efficacy. J Infect Chemother. 2017;23(11):727–732. doi: 10.1016/j.jiac.2017.09.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jiac.2017.09.001</ArticleId>
            <ArticleId IdType="pubmed">28951197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bolliger R, et al.  Validation of a Prediction Rule for Legionella Pneumonia in Emergency Department Patients. Open Forum Infect Dis. 2019;6(7):ofz268. doi: 10.1093/ofid/ofz268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ofid/ofz268</ArticleId>
            <ArticleId IdType="pmc">PMC6602791</ArticleId>
            <ArticleId IdType="pubmed">31281863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunha BA. Clinical features of legionnaires' disease. Semin Respir Infect. 1998;13(2):116–127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9643389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gadsby NJ, et al.  Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis. 2016;62(7):817–823. doi: 10.1093/cid/civ1214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/civ1214</ArticleId>
            <ArticleId IdType="pmc">PMC4787606</ArticleId>
            <ArticleId IdType="pubmed">26747825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Musher DM, Abers MS, Bartlett JG. Evolving understanding of the causes of pneumonia in adults, with special attention to the role of pneumococcus. Clin Infect Dis. 2017;65(10):1736–1744. doi: 10.1093/cid/cix549.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cix549</ArticleId>
            <ArticleId IdType="pmc">PMC7108120</ArticleId>
            <ArticleId IdType="pubmed">29028977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prendki V, et al.  Low-dose CT for the diagnosis of pneumonia in elderly patients: a prospective, interventional cohort study. Eur Respir J. 2018 doi: 10.1183/13993003.02375-2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.02375-2017</ArticleId>
            <ArticleId IdType="pmc">PMC5978575</ArticleId>
            <ArticleId IdType="pubmed">29650558</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35505308</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>05</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>08</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1471-2334</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>03</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMC infectious diseases</Title>
          <ISOAbbreviation>BMC Infect Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Accuracy of a score predicting the presence of an atypical pathogen in hospitalized patients with moderately severe community-acquired pneumonia.</ArticleTitle>
        <Pagination>
          <StartPage>424</StartPage>
          <MedlinePgn>424</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">424</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-022-07423-1</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Atypical pathogens (AP), present in some patients with community-acquired pneumonia (CAP), are intrinsically resistant to betalactam drugs, the mainstay of empirical antibiotic treatment. Adding antibiotic coverage for AP increases the risk of adverse effects and antimicrobial selection pressure, while withholding such coverage may worsen the prognosis if an AP is causative. A clinical model predicting the presence of AP would allow targeting atypical coverage for patients most likely to benefit.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">This is a secondary analysis of a multicentric randomized controlled trial that included 580 adults patients hospitalized for CAP. A predictive score was built using independent predictive factors for AP identified through multivariate analysis. Accuracy of the score was assessed using area under the receiver operating curve (AUROC), sensitivity, and specificity.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Prevalence of AP was 5.3%. Age &lt; 75 years (OR 2.7, 95% CI 1.2-6.2), heart failure (OR 2.6, 95% CI 1.1-6.1), absence of chest pain (OR 3.0, 95% CI 1.1-8.2), natremia &lt; 135 mmol/L (OR 3.0, 95% CI 1.4-6.6) and contracting the disease in autumn (OR 2.7, 95% CI 1.3-5.9) were independently associated with AP. A predictive score using these factors had an AUROC of 0.78 (95% CI 0.71-0.85). A score of 0 or 1 (present in 33% of patients) had 100% sensitivity and 35% specificity.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Use of a score built on easily obtained clinical and laboratory data would allow safe withholding of atypical antibiotic coverage in a significant number of patients, with an expected positive impact on bacterial resistance and drug adverse effects.</AbstractText>
          <AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">NCT00818610.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chauffard</LastName>
            <ForeName>Aline</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bridevaux</LastName>
            <ForeName>Pierre-Olivier</ForeName>
            <Initials>PO</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Service de Pneumologie, Centre Hospitalier du Valais Romand, Hôpital du Valais, Sion, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Carballo</LastName>
            <ForeName>Sebastian</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of General Internal Medicine, Hôpitaux Universitaires de Genève, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Prendki</LastName>
            <ForeName>Virginie</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reny</LastName>
            <ForeName>Jean-Luc</ForeName>
            <Initials>JL</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of General Internal Medicine, Hôpitaux Universitaires de Genève, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stirnemann</LastName>
            <ForeName>Jérôme</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of General Internal Medicine, Hôpitaux Universitaires de Genève, Geneva, Switzerland.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Garin</LastName>
            <ForeName>Nicolas</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Geneva, Geneva, Switzerland. Nicolas.Garin@hopitalrivierachablais.ch.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of General Internal Medicine, Hôpitaux Universitaires de Genève, Geneva, Switzerland. Nicolas.Garin@hopitalrivierachablais.ch.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Division of Internal Medicine, Hôpital Riviera Chablais, Rennaz, Switzerland. Nicolas.Garin@hopitalrivierachablais.ch.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Service de Médecine Interne, Centre Hospitalier de Rennaz, Rte du Vieux Séquoia 20, 1847, Rennaz, Switzerland. Nicolas.Garin@hopitalrivierachablais.ch.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <DataBankList CompleteYN="Y">
          <DataBank>
            <DataBankName>ClinicalTrials.gov</DataBankName>
            <AccessionNumberList>
              <AccessionNumber>NCT00818610</AccessionNumber>
            </AccessionNumberList>
          </DataBank>
        </DataBankList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>BMC Infect Dis</MedlineTA>
        <NlmUniqueID>100968551</NlmUniqueID>
        <ISSNLinking>1471-2334</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D047090">beta-Lactams</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019072" MajorTopicYN="N">Antibiotic Prophylaxis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017714" MajorTopicYN="Y">Community-Acquired Infections</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011014" MajorTopicYN="Y">Pneumonia</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
          <QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D047090" MajorTopicYN="N">beta-Lactams</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Atypical pathogen</Keyword>
        <Keyword MajorTopicYN="N">Community-acquired pneumonia</Keyword>
        <Keyword MajorTopicYN="N">Legionella pneumophila</Keyword>
        <Keyword MajorTopicYN="N">Mycoplasma pneumoniae</Keyword>
        <Keyword MajorTopicYN="N">Predictive factor</Keyword>
        <Keyword MajorTopicYN="N">Predictive score</Keyword>
      </KeywordList>
      <CoiStatement>The authors have no conflicts of interest to declare.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>23</Hour>
          <Minute>45</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35505308</ArticleId>
        <ArticleId IdType="pmc">PMC9066797</ArticleId>
        <ArticleId IdType="doi">10.1186/s12879-022-07423-1</ArticleId>
        <ArticleId IdType="pii">10.1186/s12879-022-07423-1</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Shoar S, Musher DM. Etiology of community-acquired pneumonia in adults: a systematic review. Pneumonia (Nathan) 2020;12:11. doi: 10.1186/s41479-020-00074-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s41479-020-00074-3</ArticleId>
            <ArticleId IdType="pmc">PMC7533148</ArticleId>
            <ArticleId IdType="pubmed">33024653</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Torres A, et al.  Pneumonia. Nat Rev Dis Primers. 2021;7(1):25. doi: 10.1038/s41572-021-00259-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41572-021-00259-0</ArticleId>
            <ArticleId IdType="pubmed">33833230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Torres A, et al.  The aetiology and antibiotic management of community-acquired pneumonia in adults in Europe: a literature review. Eur J Clin Microbiol Infect Dis. 2014;33(7):1065–1079. doi: 10.1007/s10096-014-2067-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10096-014-2067-1</ArticleId>
            <ArticleId IdType="pmc">PMC4042014</ArticleId>
            <ArticleId IdType="pubmed">24532008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cilloniz C, et al.  Community-acquired pneumonia related to intracellular pathogens. Intensive Care Med. 2016;42(9):1374–1386. doi: 10.1007/s00134-016-4394-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00134-016-4394-4</ArticleId>
            <ArticleId IdType="pubmed">27276986</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farr BM, et al.  Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee. Thorax. 1989;44(12):1031–1035. doi: 10.1136/thx.44.12.1031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/thx.44.12.1031</ArticleId>
            <ArticleId IdType="pmc">PMC1020880</ArticleId>
            <ArticleId IdType="pubmed">2515602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arnold FW, et al.  A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med. 2007;175(10):1086–1093. doi: 10.1164/rccm.200603-350OC.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.200603-350OC</ArticleId>
            <ArticleId IdType="pubmed">17332485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wellinghausen N, et al.  Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia. Int J Med Microbiol. 2006;296(7):485–491. doi: 10.1016/j.ijmm.2006.05.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijmm.2006.05.003</ArticleId>
            <ArticleId IdType="pubmed">16890487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Senn L, et al.  Does respiratory infection due to Chlamydia pneumoniae still exist? Clin Infect Dis. 2011;53(8):847–848. doi: 10.1093/cid/cir515.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cir515</ArticleId>
            <ArticleId IdType="pubmed">21921229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>von Baum H, et al.  Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ) BMC Infect Dis. 2009;9:62. doi: 10.1186/1471-2334-9-62.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2334-9-62</ArticleId>
            <ArticleId IdType="pmc">PMC2689234</ArticleId>
            <ArticleId IdType="pubmed">19439072</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Allgaier J, et al.  Risk factors, management, and outcomes of Legionella pneumonia in a large, nationally representative sample. Chest. 2021;159(5):1782–1792. doi: 10.1016/j.chest.2020.12.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chest.2020.12.013</ArticleId>
            <ArticleId IdType="pubmed">33352192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jain S, et al.  Community-acquired pneumonia requiring hospitalization among US adults. N Engl J Med. 2015;373(5):415–427. doi: 10.1056/NEJMoa1500245.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa1500245</ArticleId>
            <ArticleId IdType="pmc">PMC4728150</ArticleId>
            <ArticleId IdType="pubmed">26172429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Metlay JP, et al.  Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45–e67. doi: 10.1164/rccm.201908-1581ST.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.201908-1581ST</ArticleId>
            <ArticleId IdType="pmc">PMC6812437</ArticleId>
            <ArticleId IdType="pubmed">31573350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ewig S, Giesa C. Update: guidelines for the treatment and prevention of adult community-acquired pneumonia 2016: what is new? MMW Fortschr Med. 2017;159(3):51–52. doi: 10.1007/s15006-017-9278-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s15006-017-9278-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woodhead M, et al.  Guidelines for the management of adult lower respiratory tract infections–full version. Clin Microbiol Infect. 2011;17(Suppl 6):E1–59. doi: 10.1111/j.1469-0691.2011.03672.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-0691.2011.03672.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garin N, et al.  beta-Lactam monotherapy vs beta-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. JAMA Intern Med. 2014;174(12):1894–1901. doi: 10.1001/jamainternmed.2014.4887.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamainternmed.2014.4887</ArticleId>
            <ArticleId IdType="pubmed">25286173</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165(6):710–718. doi: 10.1093/aje/kwk052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/aje/kwk052</ArticleId>
            <ArticleId IdType="pubmed">17182981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Glas AS, et al.  The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56(11):1129–1135. doi: 10.1016/S0895-4356(03)00177-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0895-4356(03)00177-X</ArticleId>
            <ArticleId IdType="pubmed">14615004</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lui G, et al.  Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia. Respirology. 2009;14(8):1098–1105. doi: 10.1111/j.1440-1843.2009.01637.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1440-1843.2009.01637.x</ArticleId>
            <ArticleId IdType="pubmed">19818051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Plouffe JF. Importance of atypical pathogens of community-acquired pneumonia. Clin Infect Dis. 2000;31(Suppl 2):S35–S39. doi: 10.1086/314058.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/314058</ArticleId>
            <ArticleId IdType="pubmed">10984326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fiumefreddo R, et al.  Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department. BMC Pulm Med. 2009;9:4. doi: 10.1186/1471-2466-9-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2466-9-4</ArticleId>
            <ArticleId IdType="pmc">PMC2636761</ArticleId>
            <ArticleId IdType="pubmed">19152698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saraya T, et al.  A novel diagnostic scoring system to differentiate between Legionella pneumophila Pneumonia and Streptococcus pneumoniae Pneumonia. Intern Med. 2018;57(17):2479–2487. doi: 10.2169/internalmedicine.0491-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2169/internalmedicine.0491-17</ArticleId>
            <ArticleId IdType="pmc">PMC6172550</ArticleId>
            <ArticleId IdType="pubmed">29607950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandez-Sabe N, et al.  Clinical diagnosis of Legionella pneumonia revisited: evaluation of the Community-Based Pneumonia Incidence Study Group scoring system. Clin Infect Dis. 2003;37(4):483–489. doi: 10.1086/376627.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/376627</ArticleId>
            <ArticleId IdType="pubmed">12905131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sopena N, et al.  Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. Chest. 1998;113(5):1195–1200. doi: 10.1378/chest.113.5.1195.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.113.5.1195</ArticleId>
            <ArticleId IdType="pubmed">9596294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Viasus D, et al.  Community-acquired Legionella pneumophila pneumonia: a single-center experience with 214 hospitalized sporadic cases over 15 years. Medicine (Baltimore) 2013;92(1):51–60. doi: 10.1097/MD.0b013e31827f6104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0b013e31827f6104</ArticleId>
            <ArticleId IdType="pmc">PMC5348137</ArticleId>
            <ArticleId IdType="pubmed">23266795</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haubitz S, et al.  Ruling out Legionella in community-acquired pneumonia. Am J Med. 2014;127(10):1010.e11–9. doi: 10.1016/j.amjmed.2014.03.042.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.amjmed.2014.03.042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arancibia F, et al.  Importance of Legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago Chile. Chest. 2014;145(2):290–296. doi: 10.1378/chest.13-0162.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.13-0162</ArticleId>
            <ArticleId IdType="pubmed">23764871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Falco V, et al.  Legionella pneumophila. A cause of severe community-acquired pneumonia. Chest. 1991;100(4):1007–1011. doi: 10.1378/chest.100.4.1007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.100.4.1007</ArticleId>
            <ArticleId IdType="pubmed">1914547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gupta SK, Imperiale TF, Sarosi GA. Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia. Chest. 2001;120(4):1064–1071. doi: 10.1378/chest.120.4.1064.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.120.4.1064</ArticleId>
            <ArticleId IdType="pubmed">11591540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farnham A, et al.  Legionnaires' disease incidence and risk factors, New York, New York, USA, 2002–2011. Emerg Infect Dis. 2014;20(11):1795–1802. doi: 10.3201/eid2011.131872.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2011.131872</ArticleId>
            <ArticleId IdType="pmc">PMC4214295</ArticleId>
            <ArticleId IdType="pubmed">25513657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garcia-Vidal C, et al.  Rainfall is a risk factor for sporadic cases of Legionella pneumophila pneumonia. PLoS ONE. 2013;8(4):e61036. doi: 10.1371/journal.pone.0061036.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0061036</ArticleId>
            <ArticleId IdType="pmc">PMC3628787</ArticleId>
            <ArticleId IdType="pubmed">23613778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cilloniz C, et al.  Seasonality of pathogens causing community-acquired pneumonia. Respirology. 2017;22(4):778–785. doi: 10.1111/resp.12978.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/resp.12978</ArticleId>
            <ArticleId IdType="pubmed">28093834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kenagy E, et al.  Risk factors for Legionella longbeachae Legionnaires' disease New Zealand. Emerg Infect Dis. 2017;23(7):1148–1154. doi: 10.3201/eid2307.161429.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2307.161429</ArticleId>
            <ArticleId IdType="pmc">PMC5512494</ArticleId>
            <ArticleId IdType="pubmed">28628460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>von Baum H, Luck C. Community-acquired Legionella pneumonia: data from the CAPNETZ study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011;54(6):688–692. doi: 10.1007/s00103-011-1287-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00103-011-1287-0</ArticleId>
            <ArticleId IdType="pubmed">21626372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roed T, Schonheyder HC, Nielsen H. Predictors of positive or negative Legionella urinary antigen test in community-acquired pneumonia. Infect Dis (Lond) 2015;47(7):484–490. doi: 10.3109/23744235.2015.1021830.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/23744235.2015.1021830</ArticleId>
            <ArticleId IdType="pubmed">25761613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyashita N, et al.  Clinical presentation of legionella pneumonia: evaluation of clinical scoring systems and therapeutic efficacy. J Infect Chemother. 2017;23(11):727–732. doi: 10.1016/j.jiac.2017.09.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jiac.2017.09.001</ArticleId>
            <ArticleId IdType="pubmed">28951197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bolliger R, et al.  Validation of a Prediction Rule for Legionella Pneumonia in Emergency Department Patients. Open Forum Infect Dis. 2019;6(7):ofz268. doi: 10.1093/ofid/ofz268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ofid/ofz268</ArticleId>
            <ArticleId IdType="pmc">PMC6602791</ArticleId>
            <ArticleId IdType="pubmed">31281863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunha BA. Clinical features of legionnaires' disease. Semin Respir Infect. 1998;13(2):116–127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9643389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gadsby NJ, et al.  Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis. 2016;62(7):817–823. doi: 10.1093/cid/civ1214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/civ1214</ArticleId>
            <ArticleId IdType="pmc">PMC4787606</ArticleId>
            <ArticleId IdType="pubmed">26747825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Musher DM, Abers MS, Bartlett JG. Evolving understanding of the causes of pneumonia in adults, with special attention to the role of pneumococcus. Clin Infect Dis. 2017;65(10):1736–1744. doi: 10.1093/cid/cix549.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cix549</ArticleId>
            <ArticleId IdType="pmc">PMC7108120</ArticleId>
            <ArticleId IdType="pubmed">29028977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Prendki V, et al.  Low-dose CT for the diagnosis of pneumonia in elderly patients: a prospective, interventional cohort study. Eur Respir J. 2018 doi: 10.1183/13993003.02375-2017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.02375-2017</ArticleId>
            <ArticleId IdType="pmc">PMC5978575</ArticleId>
            <ArticleId IdType="pubmed">29650558</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
